← k3vl4r
Log inGet started →

ADCT (Adc Therapeutics SA) Price Forecast

AI-generated price forecast for Adc Therapeutics SA (ADCT) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of November 2026: K3vl4r's calibrated AI forecast currently reads ADCT as 1/1 bearish across its horizons (0 of 1 timeframes pointing up), with a last price of 1.28. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP🔬 Deep research

Last price

1.28

AI outlook

1/1 bearish

Timeframes up

0 / 1

Share𝕏PostTelegram

ADCT forecast by horizon

HorizonDirectionCalibrated move (end of horizon)
1-hour——
4-hour——
Daily~4 weeks out▼ Down-55.27%
WeeklyNot enough track record yet—

Calibrated: each horizon's forecast is weighted by how often the model has called ADCT's direction correctly over the last 30 days, and reversed where it has been wrong more often than right. A horizon votes only once it has enough resolved forecasts.

Latest ADCT news

From the market-news feed the forecasts are read against.

  • ADC Therapeutics SA Reports Third Quarter 2026 Net Product Revenue of $21.0 million and Cash of $189.2 million · Fintel · Nov 9
  • ADC Therapeutics Reports Third Quarter 2026 Financial Results and Provides Operational Updates · Yahoo · Nov 9
  • ADC Therapeutics Q3 Adj. EPS $(0.06) Beats $(0.21) Estimate, Sales $21.716M Beat $18.692M Estimate · Benzinga · Nov 9
  • ADC Therapeutics SA (ADCT) Discusses ZYNLONTA Data at ASH and Strategic Financial Restructuring - Slideshow · SeekingAlpha · Nov 7
  • BioAge Labs, Inc. (BIOA) Reports Q3 Loss, Misses Revenue Estimates · Yahoo · Nov 5

🔒

See the full ADCT forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

ADCT forecast — frequently asked

Will ADCT go up?

K3vl4r's calibrated AI forecast currently reads ADCT as 1/1 bearish — 0 of 1 forecast horizons point up, so the overall read is leaning to the downside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the ADCT price prediction for 2026?

K3vl4r's model projects ADCT toward $0.5725 over the next ~4 weeks, a -55.3% move from $1.28. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Healthcare forecasts — browse the full sector.

More AI forecasts

ACRSPTGXSABSMDHOWLLGVNSYREBBIOVNDAMLYSTRVIDYNAIMCATX

Will ADCT reach…?

Will ADCT reach $2.00?Will ADCT reach $3.00?Will ADCT reach $5.00?Will ADCT reach $10.00?

Or see the full ADCT price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare ADCT

ADCT vs ACRSADCT vs PTGXADCT vs SABSADCT vs MDADCT vs HOWLADCT vs LGVN

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rResearch libraryTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.